HER-2 Neu gene: A valuable therapeutic target in metastatic mucoepidermoid carcinoma.

Mohammed, Turab; Mangeshkar, Shaunak; Desai, Aakash; Hegde, Upendra

Mohammed, Turab; Mangeshkar, Shaunak; Desai, Aakash; Hegde, Upendra.

Afiliação

Mohammed T; Department of Internal Medicine, 12227University of Connecticut School of Medicine, University of Connecticut School of Medicine, 12227University of Connecticut School of Medicine, Farmington, CT, USA.
Mangeshkar S; Department of Internal Medicine, Seth G.S. Medical College and K.E.M Hospital, Mumbai, Maharashtra, India.
Desai A; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Hegde U; Division of Hematology and Oncology, Department of Medicine, 12227University of Connecticut School of Medicine, University of Connecticut School of Medicine, 12227University of Connecticut School of Medicine, Farmington, CT, USA.

J Oncol Pharm Pract ; 27(7): 1806-1809, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34255585

Assuntos

Neoplasias da Mama; Carcinoma Mucoepidermoide; Ado-Trastuzumab Emtansina; Idoso; Protocolos de Quimioterapia Combinada Antineoplásica; Carcinoma Mucoepidermoide/tratamento farmacológico; Carcinoma Mucoepidermoide/genética; Genes erbB-2; Humanos; Masculino; Metástase Neoplásica; Receptor ErbB-2/genética; Trastuzumab/uso terapêutico

Palavras-chave

HER-2 Neu; Mucoepidermoid carcinoma; TDM-1; Trastuzumab emtansine; metastatic salivary gland neoplasm

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Mucoepidermoide Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google